Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Whitaker

Showing results (371-380 of 385) with videos related to

Pageof 39
Sort By:
Journal of the American Chemical Society|March 24, 2026
Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific ImmunityHannah M Yamagata, Marshall S Padilla, Alex G Hamilton, et al.
European Urology|May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS CohortJoseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
Molecular Cancer|September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostatesClaudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
Scientific Reports|October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologistsLina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Cancer Research|November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
Nature|April 2, 2015
The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Nature|July 31, 2020
Author Correction: The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Pageof 39

Showing results (371-380 of 385) with videos related to

Sort By:
Pageof 39
Journal of the American Chemical Society|March 24, 2026
Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific ImmunityHannah M Yamagata, Marshall S Padilla, Alex G Hamilton, et al.
European Urology|May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS CohortJoseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
Molecular Cancer|September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostatesClaudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Radiology|December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS TrialVasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
Scientific Reports|October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologistsLina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Cancer Research|November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.
European Urology|October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMISVasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
Nature|April 2, 2015
The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Nature|July 31, 2020
Author Correction: The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Pageof 39